How to buy ClearPoint Neuro stock - 21 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy ClearPoint Neuro stock

Own ClearPoint Neuro stock in just a few minutes.

ClearPoint Neuro, Inc is a medical devices business based in the US. ClearPoint Neuro shares (CLPT) are listed on the NYSE and all prices are listed in US Dollars. ClearPoint Neuro employs 67 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in ClearPoint Neuro

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CLPT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ClearPoint Neuro share price

Use our graph to track the performance of CLPT stocks over time.

ClearPoint Neuro shares at a glance

Information last updated 2021-04-20.
52-week range$2.90 - $31.29
50-day moving average $20.59
200-day moving average $15.62
Wall St. target price$35.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Buy ClearPoint Neuro shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ClearPoint Neuro stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ClearPoint Neuro financials

Revenue TTM $12.8 million
Gross profit TTM $9.1 million
Return on assets TTM -18.76%
Return on equity TTM -194.8%
Profit margin -52.87%
Book value N/A
Market capitalisation $352.3 million

TTM: trailing 12 months

Shorting ClearPoint Neuro shares

There are currently 324,892 ClearPoint Neuro shares held short by investors – that's known as ClearPoint Neuro's "short interest". This figure is 3.6% up from 313,583 last month.

There are a few different ways that this level of interest in shorting ClearPoint Neuro shares can be evaluated.

ClearPoint Neuro's "short interest ratio" (SIR)

ClearPoint Neuro's "short interest ratio" (SIR) is the quantity of ClearPoint Neuro shares currently shorted divided by the average quantity of ClearPoint Neuro shares traded daily (recently around 569985.96491228). ClearPoint Neuro's SIR currently stands at 0.57. In other words for every 100,000 ClearPoint Neuro shares traded daily on the market, roughly 570 shares are currently held short.

However ClearPoint Neuro's short interest can also be evaluated against the total number of ClearPoint Neuro shares, or, against the total number of tradable ClearPoint Neuro shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ClearPoint Neuro's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ClearPoint Neuro shares in existence, roughly 20 shares are currently held short) or 0.0172% of the tradable shares (for every 100,000 tradable ClearPoint Neuro shares, roughly 17 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ClearPoint Neuro.

Find out more about how you can short ClearPoint Neuro stock.

ClearPoint Neuro share dividends

We're not expecting ClearPoint Neuro to pay a dividend over the next 12 months.

Have ClearPoint Neuro's shares ever split?

ClearPoint Neuro's shares were split on a 1:40 basis on 26 July 2016. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ClearPoint Neuro shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for ClearPoint Neuro shares which in turn could have impacted ClearPoint Neuro's share price.

ClearPoint Neuro share price volatility

Over the last 12 months, ClearPoint Neuro's shares have ranged in value from as little as $2.9 up to $31.29. A popular way to gauge a stock's volatility is its "beta".

CLPT.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while ClearPoint Neuro's is 1.0353. This would suggest that ClearPoint Neuro's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ClearPoint Neuro overview

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company's product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N. V.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site